Schmidt et al.
reinforces the Watson-Crick pair with cytosine (C) in
DMSO solution.6 Theoretical calculations (0 K, gas phase)
had predicted this feature of metal cations bonded at the
G-N7 site as a consequence of polarization effects.7
Interestingly, no such effects were found with adenine-N7
complexes of divalent cations (Zn2+, Cd2+, Hg2+, Mg2+,
Ca2+, Sr2+, Ba2+) applying high-level quantum mechanical
methods.8 Whether or not this result also holds up in solution
has not been studied as yet. This finding is noteworthy in
the context of A-N7 being the second most important site
of DNA bases for binding of the antitumor agent cisplatin9
and because of the considerable mutagenic potential of the
5′-ApG adduct of cisplatin with DNA.10,11
Of the other possible metal binding sites of adenine, that
is, N1,12 N3,13 and N6,14 the first one is of comparable
significance as N7, at least if the base is not involved in
Watson-Crick base pair formation (vide infra); hence, it is
free, or it may adopt Hoogsteen pairing. The other cases are
not considered here. Here, we report on our studies concern-
ing the H bonding interactions of a chloroform-soluble
platinum complex, with the metal entity fixed at N1, toward
thymine and uracil model nucleobases. Studies of this kind,
employing Pt(II) species, have proved impossible in the past
because of the insolubility of Pt(II) complexes in nonpolar
solvents on one hand, and the absence of H bonding between
A and T in polar solvents such as H2O, DMF, or DMSO on
the other. By using derivatives, carrying large organic entities
attached to the individual components to achieve sufficient
solubility,15 we have been able to circumvent these problems.
Experimental Section
Materials. 9-Cyclohexylmethyladenine (ChmA),16 1-cyclohexyl-
methylthymine (ChmTH),17 9-methyladenine (9-MeA),18 9-ethyl-
adenine (9-EtA),16 1-methylthymine (1-MeTH),19 2′,3′,5′-tri-tert-
butyldimethylsilyladenosine (TBDMS-ado),20 3′,5′-diacetyl-2′-deoxy-
uridine (and the [3-15N]-labeled compound),21 as well as trans-Pt-
22
(MeNH2)2Cl2 were prepared according to literature procedures.
trans-Pt(MeNH2)2(ChmT-N3)Cl (1). The compound was pre-
pared in a slightly modified version of that used for the corre-
sponding 1-MeT complex:23 To 0.502 g (1.531 mmol) of trans-
[Pt(MeNH2)2Cl2] in 30 mL of DMF was added 0.247 g (1.454
mmol) of AgNO3 and the reaction mixture stirred overnight. AgCl
was removed by filtration, and 0.4402 g (1.691 mmol) of the
potassium salt of 1-N-cyclohexylmethylthyminate was added to the
filtrate. After stirring at RT for 3 d, DMF was largely removed in
vacuo. Addition of diethyl ether led to isolation of 0.555 g (71%)
of analytically pure trans-Pt(MeNH2)2(ChmT-N3)Cl (1). Anal.
Calcd for C14H27N4O2ClPt: C, 32.7; H, 5.3; N, 10.9. Found: C,
32.9; H, 5.1; N, 11.0. ESI-MS: m/z 515 (M+). IR (cm-1): 3447.9
(b), 3271.9 (w), 3192.7 (m), 3106.5 (s), 2928.2 (s), 2851.8 (w),
1664.3 (vs), 1633.1 (vs), 1570.5 (vs), 1461.4 (s), 1438.1 (s), 1096.8
(m), 774.1 (m), 585.8 (w), 463.9 (w), 336.5 (w).
trans-[Pt(MeNH2)2(ChmT-N3)(ChmA-N1)]NO3 (2). It was
prepared by adding trans-[Pt(MeNH2)2(ChmT)(DMF)]NO3, ob-
tained in situ by reacting 1 with 0.95 equiv of AgNO3 in DMF
overnight at room temperature, to a solution of ChmA in DMF
and stirring the mixture for 24 h at room temperature. After rotary
evaporation of DMF, the crude product was recrystallized from
methanol/ether (20/1, v/v) to give analytically pure 2 in 30% yield.
Anal. Calcd for C26H44N10O5Pt: C, 40.5; H, 5.8; N, 18.2. Found:
C, 40.3; H, 5.6; N, 18.0. ESI-MS: m/z 709 (M+). IR (cm-1): 3379.1
(b), 3112.0 (s), 2925.9 (s), 2852.5 (m), 1660.3 (vs), 1634.2 (vs),
1557.8 (vs), 1539.3 (vs), 1534.9 (vs), 1307.4 (vs), 1104.8 (s), 827.3
(w), 776.9 (m), 719.0 (m), 652 (w).
(6) (a) Sigel, R. K. O.; Freisinger, E.; Lippert, B. J. Biol. Inorg. Chem.
2000, 5, 287. (b) Sigel, R. K. O.; Lippert, B. Chem. Commun. 1999,
2167.
(7) (a) Sponer, J.; Burda, J. V.; Sabat, M.; Leszczynski, J.; Hobza, P. J.
Phys. Chem. A 1998, 102, 5951. (b) Burda, J. V.; Sponer, J.;
Leszczynski, J.; Hobza, P. J. Phys. Chem. B 1997, 101, 9670. (c)
Anwander, E. H. S.; Probst, M. M.; Rode, B. M. Biopolymers 1990,
29, 757. (d) Hobza, P.; Sandorfy, C. J. Biomol. Struct. Dyn. 1985, 6,
1245. (e) Basch, H.; Krauss, M.; Stevens, W. J. J. Am. Chem. Soc.
1985, 107, 7267.
(8) Sponer, J.; Sabat, M.; Burda, J. V.; Leszczynski, J.; Hobza, P. J. Phys.
Chem. B 1999, 103, 2528.
(9) Fichtinger-Schepman, A. M. J.; van der Veer, J. L.; den Hartog, J. H.
J.; Lohman, P. H. M.; Reedijk, J. Biochemistry 1985, 24, 707.
(10) Burnouf, D.; Gauthier, C.; Chottard, J. C.; Fuchs, R. P. P. Proc. Natl.
Acad. Sci. U.S.A. 1990, 87, 6087.
(11) The insertion of A across the platinated 5′-base A might alternatively
be explained by an effect of the metal on the tautomer equilibrium.
See, e.g.: (a) Lippert, B.; Scho¨llhorn, H.; Thewalt, U. Inorg. Chim.
Acta 1992, 198-200, 723. (b) Burda, J. V.; Sponer, J.; Leszczynski,
J. J. Biol. Inorg. Chem. 2000, 5, 178.
(12) X-ray analysis, e.g.: (a) Schwarz, F.; Lippert, B.; Scho¨llhorn, H.;
Thewalt, U. Inorg. Chim. Acta 1990, 176, 113. (b) Arpalahti, J.; Klika,
K. D.; Sillanpa¨a¨, R.; Kiveka¨s, R. J. Chem. Soc., Dalton Trans. 1998,
1397.
trans-[Pt(MeNH2)2(ChmT-N3)(TBDMS-ado-N1)]BF4 (3). This
compound was prepared by adding trans-[Pt(MeNH2)2(ChmT-N3)-
(DMF)]BF4, obtained from 1 and AgBF4 in DMF, to a solution of
TBDMS-ado in DMF and stirring the mixture for 24 h at room
temperature. The workup of the solution was analogous to that of
2. The yield was 55%. Anal. Calcd for C42H82N9O6Si3BF4: C, 42.9;
H, 7.0; N, 10.7. Found: C, 42.3; H, 6.8; N, 10.7. ESI-MS: m/z
1088 (M+). IR (cm-1): 3273.8 (b), 2930.1 (s), 2857.5 (m), 1652.0
(s), 1567.8 (s), 1463.8 (m), 1253.4 (m), 1069.2 (vs), 836.1 (vs),
777.5 (vs), 670.1 (w), 648.8 (w).
Other reactions mentioned in the text were carried out on a NMR
scale only. N1 and N7 linkage isomers were assigned by means of
pH* dependence (pH* is uncorrected pH meter reading) of the
aromatic protons, and yields were estimated by integration of the
1
respective H NMR resonances.
(13) X-ray analysis, e.g.: Meiser, C.; Song, B.; Freisinger, E.; Peilert, M.;
Sigel, H.; Lippert, B. Chem.sEur. J. 1997, 3, 388.
(16) Nowick, J. S.; Chen, J. S.; Noronha, G. J. Am. Chem. Soc. 1993, 115,
7636.
(17) Browne, D. T.; Eisinger, J.; Leonard, N. J. J. Am. Chem. Soc. 1968,
90, 7302.
(18) Kru¨ger, G. Z. Physiol. Chem. 1893, 118, 153.
(19) Kistenmacher, T.; Rossi, M.; Caradonna, J. P.; Marzilli, L. G. AdV.
Mol. Relax. Interact. Processes 1979, 15, 119.
(20) Ogilvie, K. K. Can. J. Chem. 1973, 51, 3799.
(21) (a) Weisz, K.; Ja¨hnchen, J.; Limbach, H.-H. J. Am. Chem. Soc. 1997,
119, 6436. (b) Dunger, A.; Limbach, H.-H.; Weisz, K. Chem.sEur.
J. 1998, 4, 621.
(14) See, e.g.: (a) Clarke, M. J. J. Am. Chem. Soc. 1978, 100, 5068. (b)
Charland, J. P.; Phan Viet, M. T.; St.-Jacques, M.; Beauchamp, A. L.
J. Am. Chem. Soc. 1985, 107, 8202. (c) Lowe, G.; Vilaivan, T. J.
Chem. Soc., Perkin Trans. 1 1996, 1499. (d) Zamora, F.; Kunsman,
M.; Sabat, M.; Lippert, B. Inorg. Chem. 1997, 36, 1583. (e) Sponer,
J.; Sponer, J. E.; Gorb, L.; Leszczynski, J.; Lippert, B. J. Phys. Chem.
A 1999, 103, 11406. (f) Viljanen, J.; Klika, K. D.; Sillanpa¨a¨, R.;
Arpalahti, J. Inorg. Chem. 1999, 38, 4924. (g) Velders, A. H.; van
der Geest, B.; Kooijman, H.; Spek, A. L.; Haasnoot, J. G.; Reedijk, J.
Eur. J. Inorg. Chem. 2001, 369.
(22) Arpalahti, J.; Lippert, B.; Scho¨llhorn, H.; Thewalt, U. Inorg. Chim.
Acta 1988, 153, 45.
(23) Krizanovic, O.; Sabat, M.; Beyerle-Pfnu¨r, R.; Lippert, B. J. Am. Chem.
Soc. 1993, 115, 5538.
(15) See, e.g., 2,2′:6′,2′′-terpyridine RuII conjugate of T interacting with
2,3′-isopropylidene-adenosine: Constable, E. C.; Fallahpour, R.-A. J.
Chem. Soc., Dalton Trans. 1996, 2389.
2856 Inorganic Chemistry, Vol. 41, No. 11, 2002